- Prospective multicentre observational study across 44 hospitals, analysing 5302 videolaryngoscopic intubations with paired airway operator and observer assessments.
- Glottic view was graded by POGO score and compared with tracheal tube delivery using a three-domain classification that also covered blade geometry.
- Inter-rater agreement was high (Krippendorff's α = 0.86, 95% CI 0.85-0.87); 24.5% (37/151) of poor-view intubations (POGO < 25%) were classed as easy, while 6.3% (252/4025) with POGO > 75% were classed as difficult or failed.
- The authors conclude that intubation ease cannot be inferred from glottic view alone and suggest recording blade use, view and tube delivery together to improve communication.
Latest papers
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- This is a narrative review that synthesizes evolving evidence and international guidance on perioperative management of GLP-1 receptor agonists and SGLT2 inhibitors.
- GLP-1 receptor agonists slow gastric emptying, raising aspiration concern, but recent large-scale data reportedly show no increase in clinically significant aspiration under modern anesthetic practice.
- For GLP-1 receptor agonists, the review supports an individualized, risk-based approach with targeted mitigation for higher-risk patients rather than routine cessation.
- Perioperative guidance for SGLT2 inhibitors has converged toward preoperative discontinuation to reduce euglycemic diabetic ketoacidosis risk, and the authors emphasize anesthesiologists coordinating care that balances metabolic safety with cardiovascular and renal benefit.
- This systematic review appraised five perioperative GLP-1 receptor agonist guidelines published 2023 to 2026 using the AGREE-REX framework and reviewed their underlying primary studies.
- The review compared how the guidelines handle continuing these drugs before anesthesia, fasting modification, symptom-based risk stratification, and gastric ultrasound.
- Four of five guidelines recommend continuing the drug with structured fasting modification, replacing the 2023 ASA cessation policy, though fasting protocols still differ substantially.
- The authors conclude that guidelines share a direction but remain contested in operational details, and that prospective data on aspiration and glycemic events are urgently needed.
- Comparative cross-sectional pilot study of patients with obesity, comparing those taking GLP-1 receptor agonists with nonusers scheduled for surgery.
- Gastric point-of-care ultrasound in supine and lateral positions, with antral cross-sectional area and residual volume estimated by validated mathematical models.
- GLP-1 receptor agonist users had higher estimated gastric residual volume, and a higher proportion met ultrasound criteria for a full stomach; the abstract reports no effect sizes or p values.
- The authors conclude GLP-1 receptor agonist use was associated with a larger antrum and greater gastric contents, suggesting higher estimated aspiration risk, and propose ultrasound to guide individualized aspiration precautions.
- Systematic review and meta-analysis of 19 randomized controlled trials (n = 4,742) comparing neuraxial and general anesthesia in adults undergoing hip fracture surgery.
- Neuraxial anesthesia was compared with general anesthesia across mortality, delirium, cardiac and pulmonary complications, kidney injury, length of stay, and PONV.
- Neuraxial anesthesia was associated with lower intraoperative hypotension (RR 0.55, 95% CI 0.40-0.77), acute kidney injury (RR 0.57, 95% CI 0.38-0.84), and shorter hospital stay (MD -0.58 days, 95% CI -1.08 to -0.07).
- No significant differences were found for mortality at any time point, delirium, ACS, pneumonia, or PONV, and heterogeneity was substantial for some outcomes.
- Single-center retrospective cohort of 225 adult lung transplant recipients (2018–2023) at an academic transplant center.
- Compared patients with high perioperative lactate (upper quartile, ≥4.2 mmol/L) against those in the lower three quartiles.
- High lactate was not linked to 1-year or overall survival, but it was linked to more grade 3 primary graft dysfunction at 72 hours (42.1% vs 13.1%, p < 0.001).
- High lactate also tracked with longer ventilation (3 vs 2 days), longer ICU stay (11.6 vs 7 days), and higher in-hospital mortality (7% vs 0.6%); the authors suggest it may flag early high risk.
- In vitro simulation of six infusion-system configurations, mimicking co-loading of 1000 mL saline and norepinephrine through one peripheral catheter during cesarean delivery under spinal anesthesia.
- Norepinephrine 8 μg/mL at 30 mL/h was run alongside pressurized saline, with the pressure bag inflated to 300 mmHg, and the configurations were compared.
- Crystalloid volume at 10 minutes ranged from 596 to 947 mL across configurations (P < 0.001), and time within the norepinephrine target range ranged from 32.8% to 71.4% (P = 0.019).
- Instability ranged from 23.8% to 54.6% (P < 0.001), and the authors suggest that entering crystalloid downstream of the drug convergence may be a favorable setup, pending clinical evaluation.
- This preliminary cadaveric feasibility study placed transversus abdominis plane catheters in three anatomical bodies under combined ultrasound and micro-endoscopic guidance.
- The intervention was micro-endoscopic vision added to ultrasound guidance, with no comparator group; spread was assessed by colored dye and dissection.
- Four catheters achieved successful intended-plane dye spread, covering T8 to T12, and micro-endoscopic vision was needed for every catheter to progress along the plane.
- The authors conclude that micro-endoscopy may facilitate correct TAP catheter positioning, but they state that additional studies are needed to confirm this.
- Preclinical study in male and female rats given morphine 3 mg/kg twice daily on postnatal days 21-28, examined in adulthood.
- Morphine was compared with saline, with outcomes including withdrawal thresholds, dorsal horn electrode recordings, and immunohistochemistry for PV, PKCγ, and SOM.
- Both sexes showed reduced mechanical sensitivity at P40, while wind-up and marker changes were lamina- and sex-specific; PV rose in both sexes.
- The authors conclude that preadolescent morphine shifts dorsal horn circuit organisation in a lamina- and sex-dependent way, which may affect later pain sensitivity.
- Crossover study in 16 adult Sprague Dawley rats (8 male, 8 female) trained to proficiency on a touchscreen continuous performance task.
- Each rat received sevoflurane, propofol, ketamine, or dexmedetomidine in randomized order, and vigilance was tracked after return of righting reflex.
- Vigilance recovery was delayed after ketamine and dexmedetomidine versus baseline (HR 5.34, 95% CI 2.07 to 13.76; HR 5.33, 95% CI 2.08 to 13.62; both p<.0001).
- Dexmedetomidine also showed reward retrieval latency that had not recovered 4 hours after return of righting (-47.85% change from baseline, 95% CI -71.94 to -20.23%).
- Narrative expert review pooling RCTs, observational studies, meta-analyses, and pharmacovigilance data on GI adverse effects of GLP-1 and dual GIP/GLP-1 receptor agonists.
- Nausea, vomiting, diarrhea, and constipation are described as class effects in about 30%-50% of patients, mostly during initiation and dose escalation, and usually mild to moderate.
- Randomized data show no class-level excess acute pancreatitis risk, while cholelithiasis is a probable class association that is largely mediated by weight loss.
- The authors conclude GI events are predictable and manageable, and pipeline agents (retatrutide, survodutide, cagrilintide-semaglutide) show a similar profile, though evidence is limited.
- This narrative review summarizes the physiology of GLP-1 agonist-delayed gastric emptying and recent literature on residual gastric volume before sedated endoscopy.
- The review compares holding the GLP-1 agonist dose with continuing it alongside 24 hours of clear liquids as preventive strategies.
- Both approaches are described as effective, with a trend favoring continuation plus clear liquids, and point-of-care ultrasound is described as highly accurate for detecting residual gastric volume in experienced hands.
- The authors conclude that recent studies have considerably improved understanding of the pathophysiology and risk of residual gastric volume with these drugs.
- This multicenter cohort study matched 153 prospectively enrolled children aged 4 to 24 undergoing complex lower urinary tract reconstruction to 153 historical controls from eight hospitals.
- The intervention was a 20-element ERAS protocol implemented as standard of care, compared with care in the five years before implementation at each center.
- Median length of stay fell from 8.0 to 5.3 days (P < .001), postoperative opioid use decreased 74%, and complications fell from 72.5% to 60.1% (P = .01).
- Protocol adherence rose from 8 to 16 measures, with no differences in 90-day emergency visits, readmissions, or reoperations, and the authors concluded ERAS was highly effective.
- Multicenter, double-blind, placebo-controlled randomized trial in 1210 patients (1188 analyzed at day 30) undergoing elective curative-intent digestive cancer surgery across 23 French hospitals.
- Patients received 20 mg/kg intravenous methylprednisolone at anesthesia induction or an identical-appearing placebo.
- Major postoperative complications within 30 days did not differ significantly: 23% (139/594) with methylprednisolone vs 20% (119/594) with placebo; P = .16.
- Secondary outcomes, including postoperative infections (P = .75), intra-abdominal infections (P = .27), wound healing problems (P = .13) and length of stay (P = .93), also showed no difference; the authors advise against routine use.
- This review updates the evidence on diagnosing and managing shoulder pain, with a focus on primary care.
- Most primary care cases are nontraumatic soft-tissue problems, and subacromial pain is the most frequent source.
- Once serious causes are excluded, first-line care is education, symptom relief, activity modification if needed, and watchful waiting; early imaging is not indicated without red flags.
- High-certainty evidence shows subacromial pain does not benefit from surgery; shoulder pain is the third most common musculoskeletal presentation in primary care.
AI summary not available. Read the source abstract on PubMed.
- A retrospective case-control study at a large tertiary health system compared GLP1-RA users with matched diabetics off GLP1-RAs undergoing outpatient EGD and/or colonoscopy from 2018 to 2023.
- Cases never held their GLP1-RAs, and the authors also examined a 24-hour preprocedural liquid diet plus bowel preparation as a way to reduce gastric retention risk.
- Gastric food retention was higher in cases than controls (4.7% vs 1%, P=0.03), while inadequate bowel preparation was identical at 16.5% in both groups.
- The authors conclude GLP1-RAs raise gastric food retention independent of diabetes, and that a 24-hour liquid diet with bowel preparation appears to offset that risk.
- Systematic review and meta-analysis of 10 randomized or quasi-randomized trials (6 facet, 4 SIJ) enrolling 392 patients comparing PRP with corticosteroid injections.
- Intra- or peri-articular PRP was compared with corticosteroids, with pain scored 0-10 as the primary outcome and disability (ODI or MODQ) as the secondary outcome.
- At 3 months PRP lowered pain scores more than corticosteroids (MD -1.32, 95% CI -2.14 to -0.50; P = .0015), with the difference persisting at 6 months.
- Disability showed no significant difference at 3 months, and the authors judge the certainty of evidence limited, calling for larger trials with standardized PRP protocols.
- A cross-sectional study of 208 adults with cancer pain in a hospital-based palliative care setting used Neurometer quantitative sensory testing.
- Patients were grouped by opioid use and compared on current perception and pain thresholds for Aβ, Aδ, and C fibers, with age-adjusted analyses.
- Pain thresholds did not differ between groups, adjusted or unadjusted, and after age adjustment only Aβ current perception threshold differed significantly.
- The authors concluded that routine opioid use was not associated with clinically meaningful threshold changes, while cautioning about the cross-sectional design and residual confounding.
- This retrospective analysis of NRMP and ERAS data covers 2019-2025 pain medicine fellowship cycles, with total applicants falling from 520 to 442.
- Anesthesiology applicants dropped 70%, from 351 to 106, while physical medicine and rehabilitation applicants rose 68%, from 101 to 170.
- Positions were stable (389 to 390 from 2024 to 2025), and fill rate showed a trend toward improvement, from 82.3% to 85.4%, with regional disparities.
- The authors attribute the shift to anesthesiology workforce dynamics and reimbursement concerns and call for early exposure, mentorship, and curriculum adaptation.
- Retrospective cohort study using VA Corporate Data Warehouse records of 30,462 veterans diagnosed with fibromyalgia, with comparisons of women and men.
- Nine co-occurring chronic overlapping pain conditions and use of nonpharmacological and pharmacological fibromyalgia treatments were compared by sex using logistic regression, unadjusted and adjusted.
- Women had higher adjusted odds of a co-occurring pain condition (aOR 1.17, 95% CI 1.11-1.23) and of multimodal treatment (aOR 1.29, 95% CI 1.19-1.40), but multimodal engagement was 9% to 12% overall.
- Women were also more often prescribed cyclobenzaprine and less often pregabalin, and the authors conclude that receipt of nonpharmacological treatments was low in both sexes.
- This qualitative study interviewed 46 adolescents aged 11-21 at one and three months after common surgeries, focusing on those still using opioids in weeks 3-4 after severe pain resolved.
- Participants' experiences were analyzed without a comparator, examining how preoperative clinic conversations and recovery guidance shaped their postoperative course.
- Positive experiences included normalized anxiety, recognizing recovery milestones, and effective non-opioid and non-pharmacologic options like ice and stretching; prolonged opioid users described greater fears and caregiver-directed pain management.
- The authors conclude that realistic preoperative recovery descriptions, encouraging engagement, and education on opioid and non-opioid options, including when to stop opioids, may protect against prolonged use.
- Retrospective cohort of 1,093 chronic pain patients treated with IV lidocaine at one Israeli hospital pain clinic from 2014 to 2022, covering 15,820 infusions.
- Serious adverse outcomes were defined as emergency department visits within 14 days of infusion; predictors included cardiovascular disease, prior stroke, diabetes and cumulative infusion count.
- Fifty-five patients (5.0%) had serious adverse outcomes; more than 50 cumulative infusions was the strongest predictor (OR 12.58, P<.001), while per-infusion risk stayed stable (OR 1.00, P=.854).
- In a refined analysis limited to plausibly lidocaine-related events (n=30), pre-existing cardiovascular disease emerged as a predictor (OR 3.88, P=.008), and the authors suggest enhanced cardiac monitoring for these patients.
AI summary not available. Read the source abstract on PubMed.
- This is a theoretical framework paper, not an empirical study, and it reports no sample size, data, or measured outcomes.
- It proposes a generative model that links inferred threat to action policies, so pain intensity and pain behavior can be studied within one inferential loop.
- It argues chronic pain can persist when threat beliefs stay overly influential despite corrective evidence, and it uses placebo/nocebo and phantom pain as illustrations.
- The authors outline candidate measurements and falsifiable predictions centered on a cingulate-insula hub and descending control circuitry, and suggest stratifying patients by dominant mechanism.
- In vitro study using human iPSC-derived cortical-ganglionic eminence assembloids, characterised by immunohistochemistry and single-nucleus RNA sequencing.
- Assembloids were exposed to 96 μM propofol and compared with excitatory cortical-only organoids and with propofol plus the GABAA antagonist bicuculline.
- Propofol increased relative delta power (P=0.0078), reduced local field potential complexity (P=0.0117), and suppressed neuronal firing (P=0.0156); effects were absent in cortical-only organoids and abolished by bicuculline.
- The authors conclude that a minimal cortical circuit with functional GABAA receptors is sufficient for these anaesthetic-induced changes and propose the model for mechanistic and drug-screening work.
AI summary not available. Read the source abstract on PubMed.
- Retrospective single-center registry analysis of 404 adults undergoing minimally invasive thoracic surgery who received either thoracic paravertebral (n=121) or erector spinae plane block (n=283), 2020 to 2024.
- The authors compared TPVB with ESPB, using PACU opioid use in oral morphine equivalents as the primary outcome, adjusted with multivariable negative binomial regression.
- After adjustment, TPVB was associated with 9.4 mg less PACU opioid (95% CI -15.7 to -3.0, p<0.01) than ESPB.
- TPVB was also associated with an 11.4 min shorter time to first opioid, 118 min shorter PACU stay, and 1.2 fewer hospital days; the authors call for prospective trials.
- This commentary responds to the NIH HEAL pain research priorities report, which lists ten research priorities and five core principles.
- It focuses on Core Principle #1, which calls for including people with lived experience of pain at all stages of research, from planning to dissemination.
- The authors offer practical context for researchers starting to involve people with lived pain experience and describe how these people were included in the HEAL planning process.
- This descriptive qualitative study used semi-structured face-to-face interviews with 29 adults with low back pain, analysed by inductive reflexive thematic analysis.
- Participants were asked how they relate physical activity, stress and sleep to their pain flares, without a comparator or intervention.
- Perceived links varied widely, from no connection to complex interactions; activity was seen as either protective or provocative depending on intensity, type and context.
- Stress was perceived as an indirect link via routine, tension and awareness, and sleep as uncertain or clearly disruptive; authors note beliefs often diverged from current evidence and call for tailored education.
- This scoping review of 76 studies covered neuromuscular blockade monitoring in children under two years, searching seven databases over fifty years.
- The review charted monitoring modalities, technical considerations, and limitations, comparing mechanomyography with newer electromyography and acceleromyography.
- Earlier studies mainly used mechanomyography, while recent work has shifted toward electromyography and acceleromyography, with pediatric EMG or tri-axial AMG at the ulnar nerve favored in neonates and small infants.
- The authors conclude that reliable monitoring requires careful setup and calibration, manual supramaximal current testing may be needed if automatic measurement fails, and monitoring should continue until recovery is objectively confirmed.
- Retrospective study of 236,301 surveys from solo-anesthesiologist cases at a large U.S. anesthesia practice, June 2023 to December 2024.
- The exposure was patient-anesthesiologist concordance in age, sex, and race/ethnicity, with satisfaction measured by the highest score on the anesthesiologist rating item.
- Age concordance (OR 1.09, 95% CI 1.04 to 1.14, p = 0.001) and sex concordance (OR 1.05, 95% CI 1.01 to 1.08, p = 0.012) were linked to higher odds of the top rating; race/ethnicity concordance was not.
- In a 19,081-patient obstetric cohort, no age-concordance association was found, while race/ethnicity concordance correlated positively and sex concordance negatively with labor epidural satisfaction.
- This secondary cohort analysis of 466 adults with sepsis and respiratory failure or vasopressor-dependent shock used data from academic US hospitals.
- Baseline soluble TNF receptor 1 (sTNFR1) was examined as an exposure, with diabetes or atherosclerotic cardiovascular disease as potential effect modifiers; no intervention was given.
- Higher sTNFR1 predicted 90-day mortality without diabetes or ASCVD (HR 2.25 per sd; 95% CI 1.76-2.88), but this association was attenuated with them (overall HR 1.04; 95% CI 0.83-1.30; interaction p < 0.001).
- The effect was specific to sTNFR1, not seen with interleukin-6 or angiopoietin-2, and absent with obesity or hypertension alone, suggesting comorbidities may alter biomarker-outcome relationships.
- This review article covers sotatercept, a recombinant fusion protein for pulmonary arterial hypertension, across preclinical work, major trials, and heart failure applications.
- Sotatercept is described as a fusion of the activin receptor 2A extracellular domain with an IgG1 Fc fragment that traps activins and growth differentiation factors.
- The review examines clinical trial findings on hemodynamics, symptoms, exercise, quality of life, and mortality, but the abstract reports no effect sizes.
- The authors conclude that sotatercept gives temporally durable benefits and a striking reversal of disease consequences, and they flag adverse effects and anesthetic implications.
- This narrative review combined GLP-1 receptor agonist trial body composition data with mechanistic and surgical outcome literature, searched through March 2026.
- Direct outcome data in GLP-1 receptor agonist aesthetic surgery patients are limited to two case reports and one small cohort, so surgical implications are inferential.
- Lean soft tissue loss of about 25% to 30% of total weight lost is consistently reported across GLP-1 receptor agonist trials.
- The authors conclude that current evidence does not support changing surgical technique for GLP-1 patients as a class, but they suggest assessing body composition and considering a structured preoperative approach for high-risk patients.
- This review examines how bariatric surgery and medical weight-loss therapies affect the upper aerodigestive tract, covering mechanical, metabolic, inflammatory, and gastrointestinal effects.
- Evidence is strongest for obstructive sleep apnea, where substantial weight reduction improves severity but does not reliably lead to remission.
- Emerging data suggest possible benefits for chronic rhinosinusitis and some voice outcomes, alongside risks including reflux, chronic cough, delayed gastric emptying, and patulous Eustachian tube dysfunction.
- The authors advise otolaryngologists to account for weight-loss method, magnitude, rate, and durability in evaluation, counseling, and perioperative planning.
- Consensus development study combining a systematic review of 657 sources, four survey rounds with over 250 stakeholders, and a 26-participant consensus workshop.
- The systematic review identified 615 perioperative indicators (324 process, 248 structure, 43 unclear), mapped to a 10-domain conceptual framework.
- Surveys reduced the list to 142 indicators with high rank stability (ρ=0.89; W=0.712), and the workshop produced 56 indicators (28 core, 28 desirable).
- The authors conclude the consensus-based set reflects clinical relevance and lived experience and may be transferable to other structure and process indicator development.
- Retrospective single-centre cohort of 341,199 adults receiving propofol sedation or volatile general anaesthesia at Beth Israel Deaconess, Boston, 2008–2024.
- Exposure was cannabis use, split into medical certification versus non-medical use (recreational use or cannabis use disorder).
- Non-medical cannabis use was associated with a 6.85 μg/kg/min higher propofol dose (95% CI 6.07–7.63, P<0.001), and medical use with 2.87 μg/kg/min higher (95% CI 0.88–4.86, P=0.005).
- Volatile anaesthetic increases were small (0.01 and 0.02 MAC), and the authors concluded effect sizes were smaller than previously reported, with clinical relevance still unclear.
- Retrospective multicentre cohort from 12 Japanese tertiary hospitals in the J-PEDIA registry, analysing 4878 of 27,844 paediatric encounters with airway hyperresponsiveness.
- Compared supraglottic airway device placement with tracheal intubation during induction, using inverse probability of treatment weighting to adjust for propensity.
- SAD placement was associated with a lower adjusted risk of respiratory adverse events (aRR 0.41; 95% CI 0.19-0.62; P<0.001).
- Airway management-related adverse events (aRR 0.32; 95% CI 0.19-0.45) and severe oxygen desaturation (aRR 0.47; 95% CI 0.19-0.75) were also lower with SADs.
- A registry-based cross-sectional study of 74 adult interventional regional anesthesia trials initiated 2017-2024 that had posted results and linked publications on ClinicalTrials.gov.
- The authors compared the earliest and most recent registry versions of each trial's outcome fields to identify changes in outcome definitions, timing, and classifications.
- 91.9% of trials had at least one substantive outcome change, and 37.8% had high-impact modifications. The latest substantive change came after primary completion in 47.1% and after publication in 51.5%.
- None of these latest modifications were disclosed, and secondary outcomes were added or removed more often than primary outcomes.